SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000036104-04-000066
Filing Date
2004-01-30
Accepted
2004-01-30 09:55:33
Documents
3

Document Format Files

Seq Description Document Type Size
1 ISOLAGEN 2003 13G isolagen2003.txt SC 13G 5603
2 ISOLAGEN 2003 EXHIBIT B isolagen2003exhb.txt EX-99 548
3 ISOLAGEN 2003 EXHIBIT A isolagen2003exha.txt EX-99 361
  Complete submission text file 0000036104-04-000066.txt   9353
Mailing Address U.S.BANCORP 800 NICOLLET MALL MINNEAPOLIS MN 55402
Business Address U.S.BANCORP 800 NICOLLET MALL MINNEAPOLIS MN 55402 (612)973-1111
US BANCORP \DE\ (Filed by) CIK: 0000036104 (see all company filings)

IRS No.: 410255900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6021 National Commercial Banks

Mailing Address 2500 WILCREST 5TH FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST 5TH FLOOR HOUSTON TX 77042 713-780-4754
ISOLAGEN INC (Subject) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60307 | Film No.: 04554252
SIC: 2834 Pharmaceutical Preparations